# Rongzhi Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rongzhi-biotechnology

- Industry: Biotechnology
- Headquarters: Qingdao, China
- Website: www.each-reach.com
- Total disclosed funding: $4.6M
- Latest round: Series D (Aug 29, 2019)
- Investors on record: 9

## About

Established in 2013 and based in Qingdao, China, Rongzhi Biotechnology is a  device company that focuses on devices of gene analysis and microbial protein analysis, supplying detecting systems, analysis papers and relevant  services via the website.

## Funding rounds

- Series D, Aug 29, 2019 — Cathay Capital, Jinyuan Kuntong Equity Investment Management
- Series C, Feb 26, 2019 — Hosen Capital, Tong Sheng Capital
- Series B, Dec 7, 2017 — Hosen Capital, HosenCare Brothers
- Series B, Feb 27, 2017 — Harmony Venture, Zhengxin Capital
- Series A, Jul 1, 2016, $4.6M — Fang Fund Partners, Harmony Venture
- Angel, Dec 1, 2014 — Sangel Capital

## Investors

- Sangel Capital (https://capitalatlas.ai/funds/sangel-capital) — Angel
- Fang Fund Partners (https://capitalatlas.ai/funds/fang-fund-partners) — Series A
- Harmony Venture (https://capitalatlas.ai/funds/harmony-venture) — Series A, Series B
- Zhengxin Capital — Series B
- Hosen Capital — Series B, Series C
- HosenCare Brothers (https://capitalatlas.ai/funds/hosencare-brothers) — Series B
- Tong Sheng Capital (https://capitalatlas.ai/funds/tong-sheng-capital) — Series C
- Cathay Capital — Series D
- Jinyuan Kuntong Equity Investment Management (https://capitalatlas.ai/funds/jinyuan-kuntong-equity-investment-management) — Series D